I assume it was Dr. Susan Shore's 2017 trial that McMaster University in Canada was working with Michigan University, but I heard Dr. Larry Roberts passed away so not much went on with it...
I was going through her proposal and I have a few questions that some of you might know the answers to (it is hard to read these when I'm just hoping that this will work and it'll potentially work for me).
I'm pretty sure you have to be able to hear the audio tones for this to work, so no more than moderate hearing loss is a criteria to keep the data clean.
Generally that would mean that when you look at the audiogram, at no point before 6 kHz does the measured loss exceed something like 30 to 40 dBHL for 'mild' loss, and 40-55 dBHL for 'moderate' loss at around the tinnitus frequency. Thresholds vary, I'd have to double check what they defined it as.
For what it is worth, Dr. Shore's prior paper was published in March 2018, whereas I believe the preceding study results came in May 2017. See below links.
And also interesting to those asking about hyperacusis and listening to the device's sounds:
PDF: ClinicalTrials.gov - University of Michigan - Consent Document
"The position of the pads will be determined by the manner in which you can modulate your tinnitus."
"4.5 Am I allowed to share details about the study and my personal experience within the study to the public via Internet, tinnitus support groups, newsletters, etc.?
I can modulate mine too, so fingers crossed.
As someone based in the UK, I'd be keen to understand too. To be honest I'd be willing to travel to the US if needed.
@Samwise_The_Loud, yes, I'm UK based too. It would be interesting to see if our NHS approve it and it makes its way into audiology appointments. Lenire has not made it into any clinics (not surprisingly) which tells you all you need to know.
It is more than depressing, it is TERRIFYING to realize that Dr. Susan Shore's device seems to be our last hope to alleviate our tinnitus.
I said short-medium term, not forever...If her device doesn't make all tinnitus sufferers better, we will probably have to continue to suffer and live in isolation until we die
Your comment basically sums it up. 50 years from now, we will have an effective and safe tinnitus treatment in about 5 to 10 years...
Dammit! Get it through through your thick skulls that Dr. Shore's treatment will likely be potent treatment for a broad swath of tinnitus sufferers that will be available to all somewhere in the next 1-3 years. It's not a cure, but it will almost certainly be life changing for the majority of us to have this technique alleviate our symptoms in a meaningful way.
Personally I'm trying not to read too much into it. It could just be that the first title was too narrow and that the second one reflects more the science behind it.
The very simple explanation for that is that the device will most definitely not be called the Michigan Tinnitus Device, and that the name isn't finalised yet, which shows they're already thinking about distribution.
Michigan Tinnitus Device is a terrible marketing name.
Read nothing into that. I actually also don't think she will go into detail on Phase 2 because she's prim and proper and the write up is not published.
I also like she was given the last slot on the last day. Clearly they know everyone is going to stay to see the unveiling of results.
The positive thing is that is says "...to treat tinnitus". It doesn't say somatic tinnitus, so hopefully it will work for other causes too?
I've already addressed this. I've had an email exchange with Dr. Shore where she's confirmed that she will be presenting new information at the seminar on December 2-3.
Her reply:dj_newark said:
So in other words, she's not going to be talking about the old data from 2017. She'll be presenting based on the trial that recently concluded this year!Dr. Shore said:
Member
